Key Market Indicators
Portuguese Pharmaceutical R&D Expenditure is projected to hit approximately $230 million PPP by 2028, up from around $200 million PPP in 2023. This marks an average annual growth rate of 2.1%. Despite this upward trend, Portugal has seen a slight decline in its pharmaceutical supply, decreasing by 0.3% annually since 2012. In 2023, Portugal ranked 10th in pharmaceutical R&D expenditure, with Poland just ahead at approximately $200 million PPP. Leading the global rankings are China, Germany, and South Korea, occupying the second, third, and fourth spots, respectively.
